154 related articles for article (PubMed ID: 33128332)
1. Calculating and estimating second cancer risk from breast radiotherapy using Monte Carlo code with internal body scatter for each out-of-field organ.
Takata T; Shiraishi K; Kumagai S; Arai N; Kobayashi T; Oba H; Okamoto T; Kotoku J
J Appl Clin Med Phys; 2020 Dec; 21(12):62-73. PubMed ID: 33128332
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of organ-specific peripheral doses after 2-dimensional, 3-dimensional and hybrid intensity modulated radiation therapy for breast cancer based on Monte Carlo and convolution/superposition algorithms: implications for secondary cancer risk assessment.
Joosten A; Matzinger O; Jeanneret-Sozzi W; Bochud F; Moeckli R
Radiother Oncol; 2013 Jan; 106(1):33-41. PubMed ID: 23351844
[TBL] [Abstract][Full Text] [Related]
3. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
4. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
5. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
6. A comparison of out-of-field dose and its constituent components for intensity-modulated radiation therapy versus conformal radiation therapy: implications for carcinogenesis.
Ruben JD; Lancaster CM; Jones P; Smith RL
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1458-64. PubMed ID: 20950947
[TBL] [Abstract][Full Text] [Related]
7. Calculation of out-of-field dose distribution in carbon-ion radiotherapy by Monte Carlo simulation.
Yonai S; Matsufuji N; Namba M
Med Phys; 2012 Aug; 39(8):5028-39. PubMed ID: 22894428
[TBL] [Abstract][Full Text] [Related]
8. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
9. A critical evaluation of secondary cancer risk models applied to Monte Carlo dose distributions of 2-dimensional, 3-dimensional conformal and hybrid intensity-modulated radiation therapy for breast cancer.
Joosten A; Bochud F; Moeckli R
Phys Med Biol; 2014 Aug; 59(16):4697-722. PubMed ID: 25082795
[TBL] [Abstract][Full Text] [Related]
10. Out-of-field doses from secondary radiation produced in proton therapy and the associated risk of radiation-induced cancer from a brain tumor treatment.
Ardenfors O; Dasu A; Lillhök J; Persson L; Gudowska I
Phys Med; 2018 Sep; 53():129-136. PubMed ID: 30241747
[TBL] [Abstract][Full Text] [Related]
11. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
[TBL] [Abstract][Full Text] [Related]
12. A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.
Bednarz B; Athar B; Xu XG
Med Phys; 2010 May; 37(5):1987-94. PubMed ID: 20527532
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
[TBL] [Abstract][Full Text] [Related]
15. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source.
Suleiman SA; Qi Y; Chen Z; Xu XG
Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393
[TBL] [Abstract][Full Text] [Related]
16. Tumour size can have an impact on the outcomes of epidemiological studies on second cancers after radiotherapy.
Schneider U; Walsh L; Newhauser W
Radiat Environ Biophys; 2018 Nov; 57(4):311-319. PubMed ID: 30171348
[TBL] [Abstract][Full Text] [Related]
17. Toward automated and personalized organ dose determination in CT examinations - A comparison of two tissue characterization models for Monte Carlo organ dose calculation with a Therapy Planning System.
Källman HE; Traneus E; Ahnesjö A
Med Phys; 2019 Feb; 46(2):1012-1023. PubMed ID: 30582891
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
19. Estimating the uncertainty of calculated out-of-field organ dose from a commercial treatment planning system.
Wang L; Ding GX
J Appl Clin Med Phys; 2018 Jul; 19(4):319-324. PubMed ID: 29896876
[TBL] [Abstract][Full Text] [Related]
20. Imaging doses and secondary cancer risk from kilovoltage cone-beam CT in radiation therapy.
Kim DW; Chung WK; Yoon M
Health Phys; 2013 May; 104(5):499-503. PubMed ID: 23532078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]